한글목차

종양학 정보 시스템(OIS) 시장은 2025년 95억 2,000만 달러, 2032년에는 161억 1,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 7.8%를 나타낼 전망입니다.

종양학 정보 시스템(OIS)은 암 관리 및 치료에 중요한 역할을 합니다. 이러한 시스템은 의료 전문가에게 환자 데이터를 효과적으로 처리 및 분석하고, 치료 계획을 수립하고, 환자의 경과를 모니터링할 수 있는 종합적인 도구를 제공합니다. 전 세계적으로 암 환자가 증가함에 따라 첨단 종양학 정보 시스템(OIS)에 대한 수요가 꾸준히 증가하고 있으며, 의료 서비스 제공업체와 연구자들에게 중요한 분야가 되고 있습니다.

종양학 분야가 계속 발전함에 따라, 효율적인 정보 시스템의 필요성은 개인화된 맞춤형 암 치료를 제공하는 데 필수적인 요소로 자리 잡고 있습니다. 이러한 시스템은 워크플로우를 간소화하고, 의료진 간의 협업을 개선하며, 환자 결과를 개선하는 데 도움이 됩니다. OIS는 임상 데이터, 업무 데이터, 관리 데이터를 통합함으로써 의료 전문가가 정보에 입각한 의사결정을 내리고, 환자 개개인의 필요에 따라 맞춤형 치료 계획을 수립할 수 있도록 지원합니다.

시장 역학:

종양학 정보 시스템(OIS) 시장은 전 세계 암 발병률 증가, 헬스케어 IT 기술 발전, 개인 맞춤형 의료에 대한 수요 증가 등 다양한 요인에 의해 주도되고 있습니다. 암 발병률 증가와 더불어 효율적이고 통합된 헬스케어 솔루션의 필요성이 첨단 종양학 정보 시스템(OIS)에 대한 수요를 촉진하고 있습니다.

그러나 시장에는 높은 도입 비용, 데이터 프라이버시에 대한 우려, 기존 헬스케어 시스템으로부터의 변화에 대한 저항과 같은 억제요인도 있습니다. 이러한 문제들은 특히 자원에 제약이 있는 환경에서 종양학 정보 시스템(OIS)의 보급을 가로막는 장벽으로 작용하고 있습니다.

이러한 도전에도 불구하고, 시장에는 몇 가지 성장 기회가 있습니다. 인공지능과 머신러닝 알고리즘을 종양학 정보 시스템(OIS)에 통합하는 것은 암 진단, 치료 계획, 환자 모니터링에 혁명을 일으킬 수 있는 잠재력을 가지고 있습니다. 또한, 정밀의료에 대한 관심 증가와 개인화된 치료 접근법의 필요성은 종양학 정보시스템에 큰 성장 기회를 제공합니다.

본 조사의 주요 특징

• 세계의 종양학 정보 시스템(OIS) 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간 동안 시장 규모와 CAGR을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 종양학 정보 시스템(OIS) 시장의 주요 기업을 프로파일링합니다.
• 주요 기업으로는 Cerner Corporation, Elekta, Accuray, RaySearch Laboratories, Flatiron Health, Koninklijke Philips N.V., McKesson Corporation, Epic Systems Corporation, CureMD, CureMD, Varian Medical Systems, Inc. Epic Systems Corporation,CureMD,Varian Medical Systems, Inc. Limited 등이 있습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 종양학 정보 시스템(OIS) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매 및 승인
• PEST 분석
• PORTER 분석
• 인수합병(M&A) 시나리오

제4장 종양학 정보 시스템(OIS) 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 종양학 정보 시스템(OIS) 시장, 유형별, 2020-2032년

• 환자 정보 시스템
• 치료 계획 시스템
• 태스크 및 워크플로우 관리 시스템
• 임상시험 관리 시스템
• 기타

제6장 종양학 정보 시스템(OIS) 시장, 용도별, 2020-2032년

• 방사선 종양학
• 종양 내과
• 외과 종양학

제7장 종양학 정보 시스템(OIS) 시장, 최종사용자별, 2020년-2032년

• 종양학 센터
• 병원 및 진료소
• 진단실험실
• 의사 진료소
• 기타

제8장 종양학 정보 시스템(OIS) 시장, 지역별, 2020년-2032년

• 북미
  • 미국
  • 캐나다
• 유럽
• 영국
• 독일
• 이탈리아
• 프랑스
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
• 북아프리카
• 중앙아프리카
• 남아프리카

제9장 경쟁 구도

• Cerner Corporation
• Elekta
• Accuray
• RaySearch Laboratories
• Flatiron Health
• Koninklijke Philips N.V.
• McKesson Corporation
• Epic Systems Corporation
• CureMD
• Varian Medical Systems, Inc.
• Brainlab
• Siemens Healthcare Private Limited
• Oracle
• Karkinos Healthcare Private Limited

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Oncology Information Systems Market is estimated to be valued at USD 9.52 Bn in 2025 and is expected to reach USD 16.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Oncology Information Systems (OIS) play a crucial role in the management and treatment of cancer. These systems provide healthcare professionals with comprehensive tools to effectively handle and analyze patient data, facilitate treatment planning, and monitor patient progress. The demand for advanced oncology information systems has been steadily increasing due to the rise in cancer cases worldwide, making it a significant area of focus for healthcare providers and researchers.

As the field of oncology continues to evolve, the need for efficient information systems becomes critical in providing personalized and targeted cancer care. These systems help streamline workflow, improve collaboration among healthcare providers, and enhance patient outcomes. By integrating clinical, operational, and administrative data, OIS enables healthcare professionals to make informed decisions and develop tailored treatment plans based on individual patient needs.

Market Dynamics:

The oncology information systems market is driven by various factors including the increasing prevalence of cancer worldwide, technological advancements in healthcare IT, and growing demand for personalized medicine. The rising incidence of cancer, coupled with the need for efficient and integrated healthcare solutions, has fueled the demand for advanced oncology information systems.

However, the market also faces certain restraints such as high implementation costs, data privacy concerns, and resistance to change from traditional healthcare systems. These challenges pose barriers to the widespread adoption of oncology information systems, especially in resource-constrained settings.

Despite these challenges, the market presents several opportunities for growth. The integration of artificial intelligence and machine learning algorithms into oncology information systems has the potential to revolutionize cancer diagnosis, treatment planning, and patient monitoring. Moreover, the increasing focus on precision medicine and the need for personalized treatment approaches provide a significant growth opportunity for oncology information systems.

Key Features of the Study:

• This report provides an in-depth analysis of the global oncology information systems market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global oncology information systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Cerner Corporation, Elekta, Accuray, RaySearch Laboratories, Flatiron Health, Koninklijke Philips N.V., McKesson Corporation, Epic Systems Corporation, CureMD, Varian Medical Systems, Inc., Brainlab, Siemens Healthcare Private Limited, Oracle, and Karkinos Healthcare Private Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global oncology information systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oncology information systems market

Detailed Segmentation:

• By Type
  • Patient Information Systems Patient Information Systems
  • Treatment Planning Systems
  • Task & Workflow Management Systems
  • Clinical Trial Management Systems
  • Others
• By Application
  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology
• By End User
  • Oncology Centers
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Physician Offices
  • Others
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Cerner Corporation Cerner Corporation
  • Elekta
  • Accuray
  • RaySearch Laboratories
  • Flatiron Health
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Epic Systems Corporation
  • CureMD
  • Varian Medical Systems, Inc.
  • Brainlab
  • Siemens Healthcare Private Limited
  • Oracle
  • Karkinos Healthcare Private Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Oncology Information Systems Market , By Type
  • Oncology Information Systems Market , By Application
  • Oncology Information Systems Market , By End User
  • Oncology Information Systems Market , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Cloud-based solutions
  • Data privacy and security concerns
  • Rising prevalence of cancer globally
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Oncology Information Systems Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Oncology Information Systems Market, By Type, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis,
  • Segment Trends
• Patient Information Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, ,(US$ Bn)
• Treatment Planning Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Task & Workflow Management Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Clinical Trial Management Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Oncology Information Systems Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 -- 2032
  • Segment Trends
• Radiation Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Medical Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Surgical Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

7. Oncology Information Systems Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Physician Offices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Oncology Information Systems Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2020-2032, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By /Region, 2020-2032, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Cerner Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Elekta
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Accuray
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• RaySearch Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Flatiron Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• McKesson Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Epic Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• CureMD
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Varian Medical Systems, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Brainlab
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Siemens Healthcare Private Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Oracle
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Karkinos Healthcare Private Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us